<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: Evidence favors <z:chebi fb="0" ids="39015">apolipoprotein</z:chebi> B (apoB) over <z:chebi fb="1" ids="47774">LDL cholesterol</z:chebi> as a predictor of cardiovascular events, but data are lacking on <z:hpo ids='HP_0001717'>coronary artery calcification</z:hpo> (CAC), especially in type 2 <z:mp ids='MP_0002055'>diabetes</z:mp>, where <z:chebi fb="1" ids="47774">LDL cholesterol</z:chebi> may underestimate atherosclerotic burden </plain></SENT>
<SENT sid="1" pm="."><plain>We investigated the hypothesis that apoB is a superior marker of CAC relative to <z:chebi fb="1" ids="47774">LDL cholesterol</z:chebi> </plain></SENT>
<SENT sid="2" pm="."><plain>RESEARCH DESIGN AND METHODS: We performed cross-sectional analyses of white subjects in two community-based studies: the Penn <z:mp ids='MP_0002055'>Diabetes</z:mp> Heart Study (N = 611 type 2 diabetic subjects, 71.4% men) and the Study of Inherited Risk of <z:hpo ids='HP_0004929'>Coronary Atherosclerosis</z:hpo> (N = 803 nondiabetic subjects, 52.8% men) using multivariate analysis of apoB and <z:chebi fb="1" ids="47774">LDL cholesterol</z:chebi> stratified by <z:mp ids='MP_0002055'>diabetes</z:mp> status </plain></SENT>
<SENT sid="3" pm="."><plain>RESULTS: In type 2 <z:mp ids='MP_0002055'>diabetes</z:mp>, apoB was associated with CAC after adjusting for age, sex, and medications [Tobit regression ratio of increased CAC for 1-SD increase in apoB; 1.36 (95% CI 1.06-1.75), P = 0.016] whereas <z:chebi fb="1" ids="47774">LDL cholesterol</z:chebi> was not [1.09 (0.85-1.41)] </plain></SENT>
<SENT sid="4" pm="."><plain>In nondiabetic subjects, both were associated with CAC [apoB 1.65 (1.38-1.96), P &lt; 0.001; <z:chebi fb="1" ids="47774">LDL cholesterol</z:chebi> 1.56 (1.30-1.86), P &lt; 0.001] </plain></SENT>
<SENT sid="5" pm="."><plain>In combined analysis of diabetic and nondiabetic subjects, apoB provided value in predicting CAC scores beyond <z:chebi fb="1" ids="47774">LDL cholesterol</z:chebi>, total cholesterol, the total cholesterol/<z:chebi fb="4" ids="47775">HDL cholesterol</z:chebi> and <z:chebi fb="0" ids="17855">triglyceride</z:chebi>/<z:chebi fb="4" ids="47775">HDL cholesterol</z:chebi> ratios, and marginally beyond non-<z:chebi fb="4" ids="47775">HDL cholesterol</z:chebi> </plain></SENT>
<SENT sid="6" pm="."><plain>CONCLUSIONS: Plasma apoB, but not <z:chebi fb="1" ids="47774">LDL cholesterol</z:chebi>, levels were associated with CAC scores in type 2 diabetic whites </plain></SENT>
<SENT sid="7" pm="."><plain>ApoB levels may be particularly useful in assessing atherosclerotic burden and cardiovascular risk in type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
</text></document>